CTL 5 NOVEL PEPTIDE HAVING 5 LINKED CTL EPITOPES

摘要

Providing cancer antigen peptides that can be administered to a variety of cancer patients with a cancer peptide vaccine without the need for HLA typing and not limited to patients with a particular HLA type. CTL epitope 5 binding peptide obtained by linking through five CTL epitope peptide linkers selected from the group of CTL epitope peptides derived from tumor antigen molecules, reported to have CTL inducing ability.